Sökresultat

https://www.lusem.lu.se/internal/article/leeds-comes-lund - 2026-06-21

Gabriel Börner preferred playing pinball to studying at upper secondary school and therefore failed to get into a medical programme. Today, he is a senior consultant in surgery at Helsingborg Hospital and a researcher at Lund University. He has invented a “sewing machine” to suture patient’s wounds after abdominal surgery. Although the journey there was longer than he could ever have imagined, he

https://www.medicine.lu.se/article/needlework-surgery - 2026-06-21

Many of us have worked more remotely during the pandemic than we ever dreamed of doing. Informatics researcher Saonee Sarker has been studying IT-enabled collaboration and its impact on work-life balance for many years, but mainly with a focus on the IT sector. Today, she sees how that industry's digital settings has moved to encompass us all. The bookshelves in Saonee Sarker's office at the Schoo

https://www.staff.lu.se/article/hybrid-workplace-future - 2026-06-21

Gabriel Börner preferred playing pinball to studying at upper secondary school and therefore failed to get into a medical programme. Today, he is a senior consultant in surgery at Helsingborg Hospital and a researcher at Lund University. He has invented a “sewing machine” to suture patient’s wounds after abdominal surgery. Although the journey there was longer than he could ever have imagined, he

https://www.lunduniversity.lu.se/article/needlework-surgery - 2026-06-21

Dhalion Biotech, a new WCMM spin-off, is transforming bone cancer research. Founded by WCMM Fellow Paul Bourgine and his team, the startup uses human bone organoids to develop advanced tools for cancer modeling and drug testing. WCMM Fellow Paul Bourgine, alongside co-founders Dimitra Zacharaki and Alejandro García García, both researchers in his group, has launched Dhalion Biotech, an innovative

https://www.wcmm.lu.se/article/wcmm-fellow-launches-biotech-startup-advancing-bone-cancer-research - 2026-06-21

Among the four scholars from Lund University who have received ERC Starting Grants is Filip Lenrick, a researcher in industrial production, for the project “Bulk-like Joints by Gas Actuated Bonding”. The ERC Starting Grant is aimed at researchers in the early stages of their careers and has scientific excellence as its sole selection criterion. The researchers and their projects have been ranked t

https://www.nano.lu.se/article/erc-starting-grant-nanolundian-filip-lenrick - 2026-06-21

https://www.intramed.lu.se/en/article/after-40-years-faculty-pioneer-retiring - 2026-06-21

Ana Maria Vargas Falla was Lund University's only representative at COP29 in Baku, the capital of Azerbaijan. She has researched public resistance and acceptance of climate legislation and contributed to the "10 new insights in climate science" presented during the climate summit. These are her impressions of the United Nations Climate Change Conference. I was initially very sceptical about having

https://www.soclaw.lu.se/en/article/ana-maria-vargas-falla-reflects-cop29 - 2026-06-21

Three members share their take-aways from getting involved in an organization committed to bringing forward the voice of young researchers and teachers at the Faculty. Register for the anniversary on May 2, no later than April 20. Anders Rasmussen, 40, Associate Professor in Neuroscience & PI, Future Faculty Chair:How, when and why did you get involved in Future Faculty?"I went to a retreat in Yst

https://www.intramed.lu.se/en/article/celebrating-20-years-future-faculty-has-taught-me-how-navigate-academia - 2026-06-21

https://www.lusem.lu.se/internal/article/new-thesis-three-questions-nick-christie - 2026-06-21

This article is over 5 years old, and the information may therefore be outdated. During his studies, PhD student Fábio Rosa has been developing strategies to generate dendritic cells by direct reprogramming. Merging cellular reprogramming with immunology, this research takes new steps towards the development of novel cancer immunotherapies. Defending his thesis on June 10th, in this interview Fabi

https://www.stemcellcenter.lu.se/article/phd-defence-interview-fabio-rosa - 2026-06-21

Giulia Beneventi has investigated the role of RNA modifications and post-transcriptional control in cancer and stem cells. In this interview, she tells us about her research and what is it like to be a PhD student in newly established group. Giulia defends her thesis on the 8th of December.   What have you been working with during your PhD studies? The main aim of my PhD project was to unravel pos

https://www.stemcellcenter.lu.se/article/phd-defence-interview-giulia-beneventi - 2026-06-21

This article is over 5 years old, and the information may therefore be outdated. The programme aims to put Sweden on the map as a country that actively and critically works with the sharing economy in cities. The objectives of the programme are to: develop world-leading test-beds for the sharing economy in Stockholm, Gothenburg, Malmö and Umeå, and develop a national node, Sharing Cities Sweden, i

https://www.iiiee.lu.se/article/sharing-cities-sweden-national-programme-sharing-economy-cities - 2026-06-21

This article is over 5 years old, and the information may therefore be outdated. Focusing on Extended Producer Responsibility (EPR) policies for low carbon technologies A broad research interest in the field of environmental policy and a master’s degree in Environmental Management and Policy motivated Jessika Luth Richter to apply for PhD studies at the International Institute for Industrial Envir

https://www.iiiee.lu.se/article/meet-phd-candidate-jessika-luth-richter - 2026-06-21

PhD student Steinunn Knúts Önnudóttir not only has a background as a director, writer, theologian, life coach and actor. When she started her PhD in Lund, she was also an academic dean in her native Iceland. With the question 'How little is enough?' she has explored how little it really takes to create an artistic, transformative experience. Friday is the day of her defence. Steinunn Knúts Önnudót

https://www.agenda2030graduateschool.lu.se/article/how-little-does-it-take-create-artistic-experience - 2026-06-21

A discussion on semiconductors was on the agenda in Almedalen. The dialogue, hosted by LTH at Lund University, addressed how Sweden can contribute to the efforts being made in Europe. One of the conclusions of the discussion was "the crisper the proposal – the more policy influence". Semiconductors are a strategically important component of today's and tomorrow's society. The technology is needed

https://www.lthin.lth.se/en/article/2024/crisp-proposal-requested-during-almedalen-talk-semiconductors - 2026-06-21

Mohamed Eldeeb defended his Ph.D. thesis on June 9, 2023. With a passion for scientific discovery with clinical impact, Mohamed has dedicated the last four years to unraveling the mysteries as to why some children develop pediatric leukemia and others don’t. His research shed light on the mechanisms that prevent and suppress leukemia initiation, paving the way for more effective and targeted treat

https://www.stemcellcenter.lu.se/article/mechanisms-initiation-and-suppression-pediatric-leukemia-phd-interview-mohamed-eldeeb - 2026-06-21

On 22 September, the Swedish Chips Competence Centre (SCCC) will open in The Loop in Lund. With Lund University as the host partner, researchers, start-ups and industry partners are coming together to strengthen Sweden's and Europe's position in semiconductor technology. A shared vision for Swedish and European semiconductor technologySemiconductor technology is crucial for everything from mobile

https://www.staff.lu.se/article/sccc-takes-centre-stage-national-semiconductor-centre-opens - 2026-06-22

An antibody that did not fulfil its purpose against the disease multiple sclerosis, MS, instead made its big break in cancer research and is now starring in southern Sweden’s largest licensing agreement in Life Science history. The “father” of the antibody is Professor Carl Borrebaeck. Carl Borrebaeck. Photo: Gunnar Menander It is one of the windiest days in late summer, and the wind is blowing es

https://www.staff.lu.se/article/successful-antibody-behind-billion-crown-life-science-deal - 2026-06-21

This article is over 5 years old, and the information may therefore be outdated. An antibody that did not fulfil its purpose against the disease multiple sclerosis, MS, instead made its big break in cancer research and is now starring in southern Sweden’s largest licensing agreement in Life Science history. The “father” of the antibody is Professor Carl Borrebaeck. It is one of the windiest days i

https://www.lunduniversity.lu.se/article/successful-antibody-behind-billion-crown-life-science-deal - 2026-06-21